Overview: Cytomegalovirus IgM (CMV IgM) TestIntroduction: The Cytomegalovirus IgM Test detects IgM antibodies to cytomegalovirus, indicating recent infection causing fever or fatigue. Following 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for patients with suspected acute CMV infections.
Other Names: CMV IgM Assay, Recent CMV Infection Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: CMV antibody testing began in the 1970s with viral research. IgM-specific immunoassays emerged in the 1980s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Diagnoses recent CMV infection, guides antiviral therapy, and monitors antibody presence in patients with fever or fatigue.
Test Parameters: 1. Cytomegalovirus IgM
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like fever or fatigue, and list immunocompromising conditions.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, fatigue, or immunocompromised states (e.g., HIV, transplant). Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiviral therapy.
Procedural Considerations: Uses an immunoassay to detect CMV IgM antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Cross-reactivity with other viruses may cause false positives. Early infection may cause false negatives.
Clinical Significance: Positive IgM results confirm recent CMV infection, prompting antiviral therapy. Negative results may require PCR or viral culture.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A transplant specialist referral is advised for high-risk cases.
Additional Supporting Tests: CMV IgG, CMV PCR, or viral culture to confirm infection status.
Test Limitations: False positives may occur with related viruses. Results require clinical correlation.
References: IDSA CMV Guidelines, 2023; Clinical Infectious Diseases, Ljungman P, 2022.
